Detalhe da pesquisa
1.
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
J Allergy Clin Immunol
; 153(1): 349-353.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633651
2.
Histological characterization of liver involvement in systemic mastocytosis.
Liver Int
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554045
3.
Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score Analysis.
Transpl Int
; 36: 11775, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799669
4.
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Hematol Oncol
; 40(3): 400-408, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385885
5.
Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study.
Eur Arch Otorhinolaryngol
; 279(4): 2197-2201, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098333
6.
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.
Haematologica
; 106(7): 1867-1875, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527951
7.
Platelet transfusion refractoriness and anti-HLA immunization.
Transfusion
; 61(6): 1700-1704, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709433
8.
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Br J Haematol
; 189(2): 244-256, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030731
9.
Efficacy of bortezomib in non-IgM type I cryoglobulinaemic vasculitis: a single-centre retrospective case series.
Eur J Haematol
; 2018 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058297
10.
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Am J Hematol
; 93(6): 729-735, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473209
11.
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.
Br J Haematol
; 176(1): 37-49, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858991
12.
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 179(3): 439-448, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770576
13.
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
Hematol Oncol
; 35(4): 671-678, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27878835
14.
Bone marrow hematons: An access point to the human hematopoietic niche.
Am J Hematol
; 92(10): 1020-1031, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639326
15.
TCL1 expression patterns in Waldenström macroglobulinemia.
Mod Pathol
; 29(1): 83-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493619
16.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689746
17.
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Haematologica
; 100(12): 1587-94, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385211
18.
High-dose therapy with autologous stem cells transplantation in Bing-Neel syndrome: A retrospective analysis of 14 cases.
Am J Hematol
; 94(9): E227-E229, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31149742
19.
Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.
Am J Hematol
; 94(1): E32-E35, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370957
20.
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements.
Mol Cancer Ther
; 23(3): 272-284, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903371